Levosimendan in Europe and China: An Appraisal of Evidence and Context.
China
Levosimendan
acute heart failure
calcium sensitisation
haemodynamics
randomised controlled trials
Journal
European cardiology
ISSN: 1758-3764
Titre abrégé: Eur Cardiol
Pays: England
ID NLM: 101574780
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
10
08
2021
accepted:
27
08
2021
entrez:
24
11
2021
pubmed:
25
11
2021
medline:
25
11
2021
Statut:
epublish
Résumé
The calcium sensitiser levosimendan (SIMDAX; Orion Pharma) has been in clinical use for the management of acute heart failure and a range of related syndromes in many countries around the world for two decades. More recently, levosimendan has become available in China. The authors have examined the profile of levosimendan in clinical trials conducted inside and outside China and grouped the findings under six headings: effects on haemodynamics, effects on natriuretic peptides, effect on symptoms of heart failure, renal effects, effect on survival, and safety profile. Their conclusions are that under each of these headings there are reasonable grounds to expect that the effects and clinical benefits established in trials and with wider clinical use in Europe and elsewhere will accrue also to Chinese patients. Therefore, the authors are confident that global experience with levosimendan provides a reliable guide to its optimal use and likely therapeutic effects in patients in China.
Identifiants
pubmed: 34815750
doi: 10.15420/ecr.2021.41
pmc: PMC8591618
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e42Informations de copyright
Copyright © 2021, Radcliffe Cardiology.
Déclaration de conflit d'intérêts
Disclosure: FF and DF have recevied speaker honoraria and consultancy fees from Orion Pharma. PP is an employee of Orion Pharma. All other authors have no conflicts of interest to declare.
Références
Int J Cardiol. 2021 Sep 1;338:153
pubmed: 34118325
J Mol Cell Cardiol. 2000 Mar;32(3):479-91
pubmed: 10731446
Int J Cardiol. 2016 Sep 1;218:150-157
pubmed: 27232927
Br J Anaesth. 2009 Feb;102(2):198-204
pubmed: 19151048
Eur J Heart Fail. 2020 Apr;22(4):646-660
pubmed: 31820513
Int J Cardiol. 2016 Apr 15;209:77-83
pubmed: 26882190
JAMA. 2007 May 2;297(17):1883-91
pubmed: 17473298
Cardiology. 2014;128(2):202-8
pubmed: 24751502
JACC Heart Fail. 2013 Apr;1(2):103-11
pubmed: 24621834
Cardiovasc Drugs Ther. 2013 Dec;27(6):581-90
pubmed: 23929366
Lancet Diabetes Endocrinol. 2021 Jun;9(6):373-392
pubmed: 34022156
Glob Cardiol Sci Pract. 2012 Jul 17;2012(1):10
pubmed: 25610841
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Feb;40(2):153-6
pubmed: 22490717
J Clin Med. 2021 Mar 03;10(5):
pubmed: 33802296
Eur Heart J. 2019 Nov 21;40(44):3626-3644
pubmed: 30295807
Card Fail Rev. 2017 Apr;3(1):7-11
pubmed: 28785469
Card Fail Rev. 2020 Jul 08;6:e19
pubmed: 32714567
Front Pharmacol. 2020 Aug 26;11:1331
pubmed: 32982742
J Cardiovasc Pharmacol. 2004 Apr;43(4):555-61
pubmed: 15085067
Ann Intensive Care. 2021 Feb 8;11(1):27
pubmed: 33555483
J Card Fail. 2017 Dec;23(12):868-875
pubmed: 29029965
Int J Cardiol. 2016 Jan 1;202:138-43
pubmed: 26386941
Cardiology. 2014;128(2):195-201
pubmed: 24751462
Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):677-685
pubmed: 29718383
J Cardiovasc Pharmacol. 2018 Jan;71(1):1-9
pubmed: 29076887
BMJ Open. 2018 May 10;8(5):e020918
pubmed: 29748344
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Zhonghua Yi Xue Za Zhi. 2012 Feb 28;92(8):555-8
pubmed: 22490161
Sci Rep. 2018 May 17;8(1):7775
pubmed: 29773835
BMJ. 2020 Apr 28;369:m997
pubmed: 32345662
Card Fail Rev. 2019 Nov 04;5(3):155-161
pubmed: 31768272
J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):129-35
pubmed: 16891290
Br J Pharmacol. 2008 May;154(1):41-50
pubmed: 18297097
Med Sci Monit. 2015 Aug 20;21:2439-45
pubmed: 26289557
J Am Coll Cardiol. 2000 Nov 15;36(6):1903-12
pubmed: 11092663
J Cardiovasc Pharmacol. 2011 Feb;57(2):246-58
pubmed: 21107279
Circulation. 2008 Feb 26;117(8):1075-81
pubmed: 18268152
Expert Rev Cardiovasc Ther. 2021 Apr;19(4):325-335
pubmed: 33739204
Biomed Res Int. 2019 Sep 19;2019:9731467
pubmed: 31641670
Crit Care Med. 2013 Oct;41(10):2328-35
pubmed: 23921271
Int J Cardiol. 2012 Sep 6;159(3):225-9
pubmed: 21481958
JAMA Netw Open. 2020 Jan 3;3(1):e1918619
pubmed: 31913489
BMJ Open. 2020 Sep 28;10(9):e037331
pubmed: 32988945
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Oct 24;46(10):760-789
pubmed: 30369168
J Am Heart Assoc. 2018 Aug 21;7(16):e008455
pubmed: 30369310
Br J Pharmacol. 2009 Jan;156(2):250-61
pubmed: 19154424
Eur J Pharmacol. 1997 Aug 27;333(2-3):249-59
pubmed: 9314042
Lancet. 2002 Jul 20;360(9328):196-202
pubmed: 12133653
J Am Heart Assoc. 2019 Sep 3;8(17):e012884
pubmed: 31431117
Drug Des Devel Ther. 2018 Jul 26;12:2311-2321
pubmed: 30100706
Eur J Heart Fail. 2016 Jun;18(6):613-25
pubmed: 27324686
J Cardiovasc Pharmacol. 2019 Jan;73(1):3-14
pubmed: 30489437
Int J Cardiol. 2010 Feb 18;139(1):75-9
pubmed: 18973957
Cardiovasc Drugs Ther. 2018 Dec;32(6):617-624
pubmed: 30402660
J Am Coll Cardiol. 2014 May 20;63(19):1959-60
pubmed: 24657683
Eur Heart J Suppl. 2018 Dec;20(Suppl I):I2-I10
pubmed: 30555279
Int J Cardiol. 2016 Nov 1;222:303-312
pubmed: 27498374
Eur J Heart Fail. 2014 Mar;16(3):281-8
pubmed: 24464960
Eur J Heart Fail. 2018 Nov;20(11):1505-1535
pubmed: 29806100
J Clin Med. 2019 Nov 01;8(11):
pubmed: 31683969
Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Jun;38(6):527-30
pubmed: 21033135
Mol Cell Biochem. 2004 Nov;266(1-2):87-107
pubmed: 15646030
J Cardiovasc Pharmacol. 2009 Apr;53(4):302-10
pubmed: 19276987
Int J Environ Res Public Health. 2016 Jul 29;13(8):
pubmed: 27483300
Eur J Pharmacol. 2001 Oct 12;428(3):311-4
pubmed: 11689188
Acta Cardiol Sin. 2014 Jul;30(4):298-307
pubmed: 27122803
Cardiovasc Ther. 2013 Apr;31(2):108-14
pubmed: 23490237
Liver Transpl. 2014 Mar;20(3):361-75
pubmed: 24273004
J Cardiothorac Vasc Anesth. 2015 Dec;29(6):1415-25
pubmed: 26275522
Eur Heart J. 2002 Sep;23(18):1422-32
pubmed: 12208222
Int J Cardiol. 2019 Dec 15;297:83-90
pubmed: 31615650
J Am Coll Cardiol. 2009 Jun 23;53(25):2343-8
pubmed: 19539144
PLoS One. 2015 Apr 16;10(4):e0124742
pubmed: 25880552
Am J Cardiovasc Drugs. 2021 Jan;21(1):73-81
pubmed: 32462455